positive
Recently
NephroPlus IPO Gets SEBI Nod to Raise ₹353.4 Crore
NephroPlus secures SEBI approval for a ₹353.
Securities and Exchange Board of India (SEBI) has approved an IPO for Nephrocare Health Services, which runs the NephroPlus dialysis network. The IPO comprises a fresh issue of ₹353.4 crore plus an offer-for-sale (OFS) of 1.27 crore shares by existing shareholders.
NephroPlus plans to use proceeds to expand its dialysis clinics domestically as well as to repay debt. The Hyderabad-based firm operates over 500 centres globally across India, Nepal, Philippines, and Uzbekistan.